At BioScenergy, our teams always passionate to produce products innovations to meet local needs.
WHY CHOOSE US
We grow a wide range of medical nutrition products since 2001.
Medical nutritional range is inspired and developed using core nutritional principles,evidence based clinical research studies and quality pharmaceutical technologies. Valens formulations are designed for professional prescribing in the correct therapeutic doses to achieve therapeutic responses needed by the patients.
Niche pharmaceutical range which is catered for therapeutic areas such as:
- Veloxin – Obstetric & Gynaecology
- Vusimide – Paediatric Cardiology
- Vecobal – Neurology
- Voxytane – Urology
Nutritional range mainly use by physicians that specialised in “in-born error metabolism” (IEM). IEM is a rare genetic disorder where abnormal chemical reactions in human body disrupt food metabolism.
BioScenergy International aim of providing niche medicines support the needs of special patient groups.
We working closely with the Inborn Error Metabolism (IEM) community, BioScenergy has developed a portfolio of niche products to help enrich their lives and create a future worth living.
BioScenergy has grown into a company that specialises in medical nutrition, niche medicines and compounding medicines to improve patients’ health.
To identify and develop products in the fields of medical nutrition, niche medicines and compounding medicines to complement health care systems and improve patients’ health.
- To fulfil untapped medical needs by providing high quality niche products.
- To add value to treatment options thereby making them accessible, convenient and cost effective.
- To partner various stakeholders to complement healthcare systems.
- To enrich patients’ lives.
We has been recognized for our excellence in medical nutritions.
If you are interested in becoming a distributor or would like more information, please email us on:
GET IN TOUCH WITH US
Need additional information or have a question? Please feel free to leave us a message, and we’ll get back to you shortly.